These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15579039

  • 1. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery.
    Lanza GM, Winter P, Caruthers S, Schmeider A, Crowder K, Morawski A, Zhang H, Scott MJ, Wickline SA.
    Curr Pharm Biotechnol; 2004 Dec; 5(6):495-507. PubMed ID: 15579039
    [Abstract] [Full Text] [Related]

  • 2. Activated MR contrast agents.
    Lowe MP.
    Curr Pharm Biotechnol; 2004 Dec; 5(6):519-28. PubMed ID: 15579041
    [Abstract] [Full Text] [Related]

  • 3. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates.
    Aime S, Barge A, Cabella C, Crich SG, Gianolio E.
    Curr Pharm Biotechnol; 2004 Dec; 5(6):509-18. PubMed ID: 15579040
    [Abstract] [Full Text] [Related]

  • 4. Manganese enhanced magnetic resonance imaging.
    Lee JH, Koretsky AP.
    Curr Pharm Biotechnol; 2004 Dec; 5(6):529-37. PubMed ID: 15579042
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Possible target specific molecular imaging with ultrasound contrast agents].
    Mäurer M, Linker R, Reinhardt M, Hauff P.
    Radiologe; 2005 Jun; 45(6):560-8. PubMed ID: 15912322
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM, Lanza GA, Wickline SA.
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [Abstract] [Full Text] [Related]

  • 13. Gold nanoshell bioconjugates for molecular imaging in living cells.
    Loo C, Hirsch L, Lee MH, Chang E, West J, Halas N, Drezek R.
    Opt Lett; 2005 May 01; 30(9):1012-4. PubMed ID: 15906987
    [Abstract] [Full Text] [Related]

  • 14. Iron oxide MR contrast agents for molecular and cellular imaging.
    Bulte JW, Kraitchman DL.
    NMR Biomed; 2004 Nov 01; 17(7):484-99. PubMed ID: 15526347
    [Abstract] [Full Text] [Related]

  • 15. Characterization of image heterogeneity using 2D Minkowski functionals increases the sensitivity of detection of a targeted MRI contrast agent.
    Canuto HC, McLachlan C, Kettunen MI, Velic M, Krishnan AS, Neves AA, de Backer M, Hu DE, Hobson MP, Brindle KM.
    Magn Reson Med; 2009 May 01; 61(5):1218-24. PubMed ID: 19253374
    [Abstract] [Full Text] [Related]

  • 16. Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.
    Neubauer AM, Sim H, Winter PM, Caruthers SD, Williams TA, Robertson JD, Sept D, Lanza GM, Wickline SA.
    Magn Reson Med; 2008 Dec 01; 60(6):1353-61. PubMed ID: 19025903
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Magnetic resonance molecular imaging with nanoparticles.
    Lanza GM, Winter PM, Caruthers SD, Morawski AM, Schmieder AH, Crowder KC, Wickline SA.
    J Nucl Cardiol; 2004 Dec 01; 11(6):733-43. PubMed ID: 15592197
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J, Ochoa E, Misselwitz B, Yang D, El Naqa I, Woodard PK, Abendschein D.
    Invest Radiol; 2008 Jan 01; 43(1):49-55. PubMed ID: 18097277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.